Leading the nation’s cancer advancements through research

Massey's nationally recognized research programs comprises nearly 150 research members discovering and developing a future without cancer.

Explore our programs

One of the Nation’s leading cancer research centers

VCU Massey Comprehensive Cancer Center is proud to be your local National Cancer institute (NCI)-designated Comprehensive Cancer Center. As one of just two centers in Virginia with this distinction, Massey is at the forefront of the nation’s cancer research efforts. Massey has been designated by the NCI since 1975 and received comprehensive status in 2023.

Learn more about Massey's quest for comprehensive designation

Preeminent research programs

Massey research members conduct cutting-edge research and lead collaborative initiatives through one of three scientific research programs.

Cancer Biology

Unraveling the causes of the growth and spread of cancer and identifying key interactions between tumors and their microenvironment

Developmental Therapeutics

Discovering, developing and evaluating novel, small molecules and biologics through clinical trials

Cancer Prevention & Control

Advancing cancer risk identification and mitigation as well as improved approaches to survivorship

Research events

Research events

Massey sponsors a range of research events for trainees and researchers.

Intramural funding

Intramural funding

Explore intramural funding opportunities for novel cancer-related research concepts.

Shared resources

Shared resources

Shared resources support the extensive cancer research portfolio of Massey scientists.

Related news

View all news

Research & Innovation, Leadership

Popular weight loss, diabetes drugs linked to improved breast cancer survival

May 11, 2026

New research published today in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients....

Research & Innovation

Targeted biological missile blocks growth of aggressive leukemia

Apr 29, 2026

New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly prevents leukemia progression, improves survival rates and minimizes damage to surrounding healthy tissue. ...